Literature DB >> 12496476

A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein.

Terri Worley1, Johan Vallon-Christersson, Blase Billack, Ake Borg, Alvaro N A Monteiro.   

Abstract

Recent evidence suggests that the breast and ovarian cancer susceptibility gene product BRCA1 is involved in at least two fundamental cellular processes: transcriptional regulation and DNA repair. However, the mechanism of action of BRCA1 in either of these processes is still unknown. Here, we report the characterization of a disease-predisposing allele of BRCA1, identified in a family with several cases of ovarian cancer, coding for a protein that displays temperature-sensitive activity in transcriptional activation. The mutant protein differs from the wild type protein at a single amino acid, R1699W that occurs in a region at the N-terminal BRCT domain that is highly conserved among BRCA1 homologs. When the C-terminus of the mutant protein (aa 1560-1863) was fused to a heterologous GAL4 DNA-binding domain and expressed in yeast or mammalian cells, it was able to activate transcription of a reporter gene to levels observed for wild type BRCA1 at the permissive temperature (30 degrees C) but exhibited significantly less transcription activity at the restrictive temperature (37 degrees C or 39 degrees C). Our results indicate that the transcriptional activity of the R1699W mutant can be modulated as a function of temperature and provide a novel experimental approach which can be utilized to dissect the molecular mechanism(s) of BRCA1 in processes related to transcription.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496476     DOI: 10.4161/cbt.1.5.164

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  10 in total

Review 1.  Functional assays for BRCA1 and BRCA2.

Authors:  Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Int J Biochem Cell Biol       Date:  2006-08-18       Impact factor: 5.085

2.  Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.

Authors:  Vanessa C Fernandes; Volha A Golubeva; Giuliano Di Pietro; Cara Shields; Kwabena Amankwah; Thales C Nepomuceno; Giuliana de Gregoriis; Renata B V Abreu; Carly Harro; Thiago T Gomes; Ricceli F Silva; Guilherme Suarez-Kurtz; Fergus J Couch; Edwin S Iversen; Alvaro N A Monteiro; Marcelo A Carvalho
Journal:  J Biol Chem       Date:  2019-02-14       Impact factor: 5.157

3.  Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.

Authors:  P K Lovelock; S Healey; W Au; E Y M Sum; A Tesoriero; E M Wong; S Hinson; R Brinkworth; A Bekessy; O Diez; L Izatt; E Solomon; M Jenkins; H Renard; J Hopper; P Waring; S V Tavtigian; D Goldgar; G J Lindeman; J E Visvader; F J Couch; B R Henderson; M Southey; G Chenevix-Trench; A B Spurdle; M A Brown
Journal:  J Med Genet       Date:  2005-05-27       Impact factor: 6.318

4.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

Review 5.  Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation.

Authors:  Alvaro N Monteiro; Peter Bouwman; Arne N Kousholt; Diana M Eccles; Gael A Millot; Jean-Yves Masson; Marjanka K Schmidt; Shyam K Sharan; Ralph Scully; Lisa Wiesmüller; Fergus Couch; Maaike P G Vreeswijk
Journal:  J Med Genet       Date:  2020-03-09       Impact factor: 6.318

6.  BRCA1 Circos: a visualisation resource for functional analysis of missense variants.

Authors:  Ankita Jhuraney; Aneliya Velkova; Randall C Johnson; Bailey Kessing; Renato S Carvalho; Phillip Whiley; Amanda B Spurdle; Maaike P G Vreeswijk; Sandrine M Caputo; Gael A Millot; Ana Vega; Nicolas Coquelle; Alvaro Galli; Diana Eccles; Marinus J Blok; Tuya Pal; Rob B van der Luijt; Marta Santamariña Pena; Susan L Neuhausen; Talia Donenberg; Eva Machackova; Simon Thomas; Maxime Vallée; Fergus J Couch; Sean V Tavtigian; J N Mark Glover; Marcelo A Carvalho; Lawrence C Brody; Shyam K Sharan; Alvaro N Monteiro
Journal:  J Med Genet       Date:  2015-02-02       Impact factor: 6.318

7.  Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1.

Authors:  Renato S Carvalho; Renata B V Abreu; Aneliya Velkova; Sylvia Marsillac; Renato S Rodarte; Guilherme Suarez-Kurtz; Edwin S Iversen; Alvaro N A Monteiro; Marcelo A Carvalho
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

Review 8.  BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.

Authors:  Abdelilah Laraqui; Nancy Uhrhammer; Hicham E L Rhaffouli; Yassine Sekhsokh; Idriss Lahlou-Amine; Tahar Bajjou; Farida Hilali; Jamila El Baghdadi; Abderrahmane Al Bouzidi; Youssef Bakri; Said Amzazi; Yves-Jean Bignon
Journal:  Dis Markers       Date:  2015-02-28       Impact factor: 3.434

Review 9.  The life and death of RNA across temperatures.

Authors:  Attila Becskei; Sayanur Rahaman
Journal:  Comput Struct Biotechnol J       Date:  2022-08-08       Impact factor: 6.155

10.  Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.

Authors:  Abdelilah Laraqui; Nancy Uhrhammer; Idriss Lahlou-Amine; Hicham El Rhaffouli; Jamila El Baghdadi; Mohamed Dehayni; Rahali Driss Moussaoui; Mohamed Ichou; Yassir Sbitti; Abderrahman Al Bouzidi; Said Amzazi; Yves-Jean Bignon
Journal:  Int J Med Sci       Date:  2012-12-10       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.